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Introduction
• “A trauma patient’s greatest risk of death 
after the first 24 hours of injury stems 
from a combination of 3 conditions: 
hypothermia, acidosis, and coagulopathy” 
(Katrancha & Gonzalez, 2014).
• “Unless this cycle can be broken, the 
patient’s death is unavoidable” (Mizobata, 
2017).
• Viscoelastic tests such as 
thromboelastogram (TEG) provide real 
time assessment of blood properties to 
help guide correction of  the trauma triad 
(Pigna, Lippi, Saronni, & Cervellin, 2018).
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Working in the trauma population, a 
significant pathophysiological issue is the “lethal 
triad” stemming from various forms of injury 
(Mizobata, 2017, p. 2). The triad is comprised of 
the three variables that contribute the most to a 
patient’s risk for mortality: hypothermia, 
acidosis, and coagulopathy. Critical care 
management of this triad is largely focused on 
resuscitation of the hemorrhagic and 
coagulopathic population to aide in restoring 
natural physiologic function (Katrancha & 
Gonzalez, 2014, p. 61). With that, recent studies 
have sought out the efficacy of utilizing TEG to 
guide resuscitation during this high acuity phase 
(Mohamed et al., 2017, pp. 2-3).
This complex pathophysiological process is 
often seen in critical care. In the trauma 
population, “uncontrolled hemorrhage” is the 
isolated cause of death in forty percent of 
patients (Mizobata, 2017, p. 1). Moving forward, 
effective treatment and reduction of this 
percentage will be based upon rapid reversal of 
the lethal triad. To accomplish this, an emphasis 
on restoration of clotting factors, optimal 
understanding of guided massive transfusion 
protocol, and surgical management must be 
understood (Mizobata, 2017, pp. 4-7).






Many differentials causing trauma induced coagulopathy require surgical 
intervention outside of the intensive care unit. However, preoperatively and 
postoperatively, nursing management of patient’s with TIC revolves around 
identification and treatment of major symptoms of the pathological process 
(Mizobata, 2017).  Nursing facilitated or inclusive implications of care include 
management of the following issues:
• Hypothermia must be combatted with active rewarming. Interventions 
include warmed intravenous fluids, heated blankets, and avoidance of 
exposure to ambient cooling.
• Preventing and identifying metabolic acidosis is integral in patient 
outcomes. Prevention of acidosis largely focuses on hemodynamic 
stability. Monitor for signs of inadequate end organ perfusion such as 
altered levels of consciousness and a decrease in urinary output.
• Appropriate and effective fluid resuscitation is imperative. Use of TEG 
accurately guides resuscitation with necessary blood products. TEG 
enhances the ability to avoid excessive crystalloid or colloid 
administration. 
• Efficient administration of large amounts of blood products including 
packed red blood cells, fresh frozen plasma, platelets, cryoprecipitate, 
and more. Administration of these products facilitate the restoration of 
clotting factors lost during hemorrhage.
• Allowance of permissive hypotension in the absence of brain injury. 
Permissive hypotension promotes clot formation, but hypoperfusion of 
injured brain tissue can worsen injury. Without neurological damage, 
aim for a systolic blood pressure of 90mmHg.
• Consider pharmacological measures that may be in play. Many 
prescribed medications affect clotting capabilities and may require 
pharmacological reversal.
• Frequent assessment of vital signs, point of care labs, and serum labs 
to support clinical interventions advised per TEG guidelines. 
(Katrancha & Gonzalez, 2014)
TIC is a medical emergency. With unmanaged hypothermia, acidosis, 
and coagulopathy, this pathological process advances without relent. 
Optimal outcomes are dependent upon rapid triage of injury and 
identifying appropriate treatment. Often, surgical measures are indicated. 
Preoperatively and postoperatively, care is focused on combatting the 
lethal triad. A major intervention for combatting coagulopathy is 
resuscitation with blood products. 
Due to recent advancements in medical knowledge, the guidance of 
resuscitation can now be more effectively implemented with the utilization 
of TEG. The use of TEG has proven to be cost effective and incredibly 
beneficial in the reduction of mortality rates in the high acuity phase of TIC. 
Further studies are indicated to continually enhance the knowledge base 
that is available – especially as resuscitation with whole blood gains 
momentum in many clinical trials. 
(Haemonetics, 2019)
(Hess et al., 2008)
Primary labs for patient’s experiencing TIC should be focused on 
TEG. This test provides a real time assessment of factors related to 
coagulopathy. With an understanding of TEG normal physiological 
values, appropriate resuscitation can be achieved with less blood 
products. Fewer, more effective, transfusions minimizes risks, 
complications, and cost of care (Mohamed et al., 2017). 
Components of TEG include time to clot initiation (ACT or R-value), 
speed of clot formation (K-value and Alpha angle), strength of clot 
(MA), and how much clot lysis has occurred after 30 minutes (LY30).
Normal Values
• R: 4 to 8 minutes
• K: 1 to 4 minutes
• Alpha angle: 47-74 degrees
• MA: 55-73mm
• LY30: 0 to 8%
(Phillips, Mohorn, Bookstaver, Ezekiel, & Watson, 2017)
Treatment
• Prolonged R: Fresh Frozen 
Plasma or protamine
• Prolonged K/Reduced angle: 
cryoprecipitate
• Reduced MA: platelets
• Elevated LY30: Tranexamic 
acid
TIC has numerous symptoms that manifest as a result of an initial 
injury. Many symptoms are compounding and intertwined as a direct 
result of the pathophysiology of the lethal triad. While numerous 
symptoms will vary based upon mechanism of injury, common 
manifestations of the severely compromised TIC patient include:
• Altered levels of consciousness
• Hypothermia – body core temperature of less than 36.5⁰C
• Metabolic acidosis – hypoperfusion may induce lactic acid 
accumulation
• Coagulopathy - inability to clot worsens with loss of factors
• Hypotension – due to acidosis, impaired cardiac performance, and 
volume loss
• Hemorrhagic hypovolemia
TIC is propagated by a cascade of physiological events, but the cycle is initiated by a severe injury. 
Regardless of mechanism such as blunt force or penetrating trauma, TIC can be manifested and will 
quadruple mortality compared to a trauma without TIC (Phillips, Mohorn, Bookstaver, Ezekiel, & Watson, 
2017). After injury, coagulopathy issues manifest because of variables such as hypothermia, acidosis, 
hypoperfusion, and hemodilution. 
Acute trauma promotes hemorrhage due to injury to organs or bone. As hemorrhage persists, several 
variables escalate. Loss of volume from hemorrhage results in hypotension and hypoperfusion; two lethal 
variables that are clinically addressed. Notably, hypoperfusion in the trauma patient is linked to the 
conversion of Protein C to Activated Protein C (APC). This is significant because APC inhibits cofactors that 
lead to the production of thrombin. Additionally, APC leads to an overactive tissue plasminogen activator 
in the body; rapid conversion of clotting factors ensues leading to excessive bleeding. Hypoperfusion also 
leads to the body’s transition to anaerobic metabolism resulting in the accumulation of lactic acid. As lactic 
acid accumulates, metabolic acidosis worsens. Acidosis itself causes further disorders within the clotting 
cascade leading to prolonged clotting times and inferior clot performance. Furthermore, this hypotension 
and acidosis are frequently combatted with crystalloid resuscitation such as 0.9% sodium chloride while 
waiting for the delivery of blood products from the lab. The crystalloid resuscitation further antagonizes a 
hyperchloremic acidosis and leads to a dilution of blood and coinciding clotting factors.
Throughout the entire treatment of TIC, the patient is exposed to risk factors that contribute to 
worsening hypothermia. This issue begins when the patient is immediately affected by the trauma. At this 
point, the patient is exposed to whatever the environmental temperature may be. Additionally, when first 
responders arrive, clothing is often removed to visualize the full extent of trauma. Treatment includes 
room temperature or colder resuscitation with fluids such as chilled blood products. Depending on severity 
or mechanism of injury, a patient may also be exposed to the cold setting of the operating room to correct 
the insult that has occurred. This hypothermia is noteworthy because it further hinders the body’s ability 
and drive to manufacture clotting factors.
(Katrancha & Gonzalez, 2014)
Effective utilization of TEG can optimize the ability to combat TIC. Data generated from TEG results 
helps to combat pathological issues worsened by non TEG management. Traditional management of TIC 
focuses resuscitation at a 1:1:1 ratio of PRBC, FFP, and platelets. TEG, with its in-depth and real time 
analysis of lacking clotting factors, provides the ability to generate effective clotting factors with less 
volume. This combination promotes coagulation while combatting excessive exposure to the negative 
properties of hypotension and hypothermia. Utilization of TEG also contributes to a reduction in critical 
care days and length of stay. Effective management of transfusions is patient specific. Algorithms outside 
of those generated by real time analysis will be based upon educated guesses rather than patient specific 
scenarios.
(Mohamed et al., 2017
